• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用作示踪剂时,挥发性镁螯合物的质谱分析用于稳定26Mg的测量。

Mass spectrometry of a volatile Mg chelate in the measurement of stable 26Mg when used as a tracer.

作者信息

Schwartz R, Giesecke C C

出版信息

Clin Chim Acta. 1979 Sep 15;97(1):1-8. doi: 10.1016/0009-8981(79)90018-4.

DOI:10.1016/0009-8981(79)90018-4
PMID:498517
Abstract

A method for the detection of 26Mg enrichment of natural Mg was developed based on mass spectrometry (MS) of a Mg chelate made by complexing Mg to 2,2',6,6'-tetramethylheptanedione (THD). The chelate [Mg(THD)2] was extracted at pH greater than 9 from dilute aqueous solutions into ethyl ether, recovered by sublimation at room temperature, and introduced by solid probe into a Finnigan 3300 mass spectrometer. The chelate was ionized by electron impact. Samples were heated to a maximum temperature of 200 degrees C at a rate of 700 degrees C/h. Each analysis required 1--5 micrograms Mg(THD)2. Enrichment levels as low as 5% above natural abundance could be detected satisfactorily. Precision was best at 26Mg enrichment levels of 8--40% above natural abundance, the levels most likely to be encountered in analysis of plasma, urine and fecal samples from experimental subjects who had received 26Mg as a tracer. The method was compared to neutron activation (NA) analysis and judged superior.

摘要

基于镁与2,2',6,6'-四甲基庚二酮(THD)络合形成的镁螯合物的质谱分析(MS),开发了一种检测天然镁中26Mg富集的方法。螯合物[Mg(THD)2]在pH大于9的条件下从稀水溶液中萃取到乙醚中,通过室温升华回收,并通过固体探针引入菲尼根3300质谱仪。螯合物通过电子轰击电离。样品以700℃/h的速率加热至最高温度200℃。每次分析需要1 - 5微克Mg(THD)2。可以令人满意地检测到比天然丰度低至5%的富集水平。在比天然丰度高8 - 40%的26Mg富集水平下精度最佳,这是在接受26Mg作为示踪剂的实验对象的血浆、尿液和粪便样本分析中最可能遇到的水平。该方法与中子活化(NA)分析进行了比较,并被判定更优。

相似文献

1
Mass spectrometry of a volatile Mg chelate in the measurement of stable 26Mg when used as a tracer.用作示踪剂时,挥发性镁螯合物的质谱分析用于稳定26Mg的测量。
Clin Chim Acta. 1979 Sep 15;97(1):1-8. doi: 10.1016/0009-8981(79)90018-4.
2
26Mg as a probe in research on the role of magnesium in nutrition and metabolism.
Fed Proc. 1982 Aug;41(10):2709-13.
3
Magnesium isotopic abundance measurement in humans: comparison of two mass spectrometric methods.人体中镁同位素丰度的测定:两种质谱方法的比较
Magnes Res. 1998 Jun;11(2):91-102.
4
Measurement of magnesium absorption in man using stable 26Mg as a tracer.
Clin Chim Acta. 1978 Jul 15;87(2):265-73. doi: 10.1016/0009-8981(78)90347-9.
5
Evaluation of 26Mg stable isotope as an in vivo tracer of magnesium transport for SIMS ion microscopy imaging studies.
J Microsc. 1997 Nov;188(Pt 2):182-90. doi: 10.1046/j.1365-2818.1997.2480806.x.
6
A compartmental model of magnesium metabolism in healthy men based on two stable isotope tracers.基于两种稳定同位素示踪剂的健康男性镁代谢的房室模型。
Am J Physiol Regul Integr Comp Physiol. 2003 Sep;285(3):R656-63. doi: 10.1152/ajpregu.00749.2002. Epub 2003 May 29.
7
Comparison of stable-isotope-tracer methods for the determination of magnesium absorption in humans.用于测定人体镁吸收的稳定同位素示踪方法比较
Am J Clin Nutr. 2003 May;77(5):1206-12. doi: 10.1093/ajcn/77.5.1206.
8
Determination of isotope enrichments of magnesium in microwave-digested biological samples by thermal ionization mass spectrometry using a direct loading technique.采用直接进样技术通过热电离质谱法测定微波消解生物样品中镁的同位素丰度。
Analyst. 1996 Jul;121(7):901-4. doi: 10.1039/an9962100901.
9
Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection.甘氨酸镁与氧化镁在回肠切除患者中的生物利用度
JPEN J Parenter Enteral Nutr. 1994 Sep-Oct;18(5):430-5. doi: 10.1177/0148607194018005430.
10
Elemental isotopic abundance determinations of magnesium in biological materials by secondary ion mass spectrometry.通过二次离子质谱法测定生物材料中镁的元素同位素丰度
Anal Chem. 1984 Mar;56(3):402-7. doi: 10.1021/ac00267a023.

引用本文的文献

1
Use of the stable isotopes technique to evaluate the bioavailability of a pharmaceutical form of magnesium in man.
Pharm Res. 1998 Feb;15(2):347-51. doi: 10.1023/a:1011947525377.